According to the enterprise research app, Nanjing Haoyuan New Drug Research and Development Co., Ltd. was recently established. The legal representative is Zhou Zhiguo, with a registered capital of 10 million yuan. The business scope includes: medical research and experimental development; sales of specialty chemical products; new material technology research and development; import and export of goods, etc. Enterprise investigation and equity penetration revealed that the company is wholly owned by Haoyuan Pharmaceutical.

Zhitongcaijing · 1d ago
According to the enterprise research app, Nanjing Haoyuan New Drug Research and Development Co., Ltd. was recently established. The legal representative is Zhou Zhiguo, with a registered capital of 10 million yuan. The business scope includes: medical research and experimental development; sales of specialty chemical products; new material technology research and development; import and export of goods, etc. Enterprise investigation and equity penetration revealed that the company is wholly owned by Haoyuan Pharmaceutical.